Dr. Badihian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Avenue
Neurological Institute
Cleveland, OH 44195
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 2022 - 2026
Isfahan University of Medical SciencesClass of 2016
Certifications & Licensure
OH State Medical License 2024 - 2026
Clinical Trials
- Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients Start of enrollment: 2015 Apr 01
- Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients Start of enrollment: 2015 Sep 01
- Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients Start of enrollment: 2017 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsQuantifying Induced Nystagmus Using a Smartphone Eye Tracking Application (EyePhone).Pouya B Bastani, Hector Rieiro, Shervin Badihian, Jorge Otero-Millan, Nathan Farrell
Journal of the American Heart Association. 2024-01-16 - 124 citationsComparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.Zahra Nikoo, Shervin Badihian, Vahid Shaygannejad, Nasrin Asgari, Fereshteh Ashtari
Journal of Neurology. 2017-08-22 - 21 citationsLong-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective studyVahid Shaygannejad, Emad Fayyazi, Shervin Badihian, Omid Mirmosayyeb, Navid Manouchehri
Journal of Neurology. 2019-01-11
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
